A review of the cost-effectiveness of genetic testing for germline variants in familial cancer-Reference-Cited by-同舟云学术

A review of the cost-effectiveness of genetic testing for germline variants in familial cancer

Published:2022-12-16 Issue:1 Volume:26 Page:19-33
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Teppala Srinivas¹^ORCID,Hodgkinson Brent¹^ORCID,Hayes Sandi²^ORCID,Scuffham Paul¹²^ORCID,Tuffaha Haitham³^ORCID

Affiliation:

1. Centre for Applied Health Economics, Griffith University, Nathan, Australia

2. Menzies Health Institute Queensland, Griffith University, Southport, Australia

3. Centre for the Business and Economics of Health, The University of Queensland, St. Lucia, Australia

Funder

Griffith University

Priority Impact Research Award – Future

Publisher

Informa UK Limited

Subject

Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.1080/13696998.2022.2152233

Reference91 articles.

1. NCCN. 2022. Clinical practice guidelines in oncology, breast cancer. Version 4.2022. Avaialble from: https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf.

2. NCCN. 2022. Clinical practice guidelines in oncology, colon cancer. Version 1.2022. Avaialble from: https://www.nccn.org/professionals/physician_gls/pdf/colon.pdf.

3. NCCN. 2022. Clinical practice guidelines in oncology, ovarian cancer including fallopian tube cancer and primary peritoneal cancer. Version 4.2022. Avaialble from: https://www.nccn.org/professionals/physician_gls/pdf/ovarian.pdf

Frequency of germline mutations in BRCA1 and BRCA2 in ovarian cancer patients and their effect on treatment outcome

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aspiring toward equitable benefits from genomic advances to individuals of ancestrally diverse backgrounds;The American Journal of Human Genetics;2024-05

2. Cascade testing for hereditary cancer in Singapore: how population genomics help guide clinical policy;Familial Cancer;2024-04-25

3. Strategies to improve implementation of cascade testing in hereditary cancer syndromes: a systematic review;npj Genomic Medicine;2024-04-03

4. Economic evaluation of germline genetic testing for breast cancer in low- and middle-income countries: a systematic review;BMC Cancer;2024-03-07

5. Unraveling germline predisposition in hematological neoplasms: Navigating complexity in the genomic era;Blood Reviews;2023-11